- Home
- SONN vs TCRT Comparison
SONN vs TCRT Comparison
Compare SONN & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- TCRT
- Stock Information
- Founded
- SONN N/A
- TCRT 1998
- Country
- SONN United States
- TCRT United States
- Employees
- SONN N/A
- TCRT N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- SONN Health Care
- TCRT Health Care
- Exchange
- SONN Nasdaq
- TCRT Nasdaq
- Market Cap
- SONN 3.3M
- TCRT 3.8M
- IPO Year
- SONN N/A
- TCRT N/A
- Fundamental
- Price
- SONN $2.98
- TCRT $2.39
- Analyst Decision
- SONN Strong Buy
- TCRT
- Analyst Count
- SONN 3
- TCRT 0
- Target Price
- SONN $117.33
- TCRT N/A
- AVG Volume (30 Days)
- SONN 1.4M
- TCRT 15.9K
- Earning Date
- SONN 12-12-2024
- TCRT 11-14-2024
- Dividend Yield
- SONN N/A
- TCRT N/A
- EPS Growth
- SONN N/A
- TCRT N/A
- EPS
- SONN N/A
- TCRT N/A
- Revenue
- SONN $55,881.00
- TCRT $7,000.00
- Revenue This Year
- SONN N/A
- TCRT N/A
- Revenue Next Year
- SONN N/A
- TCRT N/A
- P/E Ratio
- SONN N/A
- TCRT N/A
- Revenue Growth
- SONN N/A
- TCRT N/A
- 52 Week Low
- SONN $2.50
- TCRT $1.95
- 52 Week High
- SONN $18.72
- TCRT $33.00
- Technical
- Relative Strength Index (RSI)
- SONN 30.17
- TCRT 54.94
- Support Level
- SONN $2.50
- TCRT $2.07
- Resistance Level
- SONN $3.50
- TCRT $2.38
- Average True Range (ATR)
- SONN 0.85
- TCRT 0.21
- MACD
- SONN 0.00
- TCRT 0.04
- Stochastic Oscillator
- SONN 6.38
- TCRT 48.35
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.